Health-Related Quality of Life in Patients With Locally Advanced Prostate Cancer After 76 Gy Intensity-Modulated Radiotherapy vs. 70 Gy Conformal Radiotherapy in a Prospective and Longitudinal Study

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 3, 2007, Pages 656-661

  Lips, Irene ^a   Dehnad, Human ^a   Kruger, Arto Boeken ^a   van Moorselaar, Jeroen ^b   van der Heide, Uulke ^a   Battermann, Jan ^a   van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dose escalation; Intensity modulated radiotherapy (IMRT); Position verification; Prostate cancer; Quality of life (QoL)

Indexed keywords

BIOACTIVITY; DOSIMETRY; HEALTH RISKS; ONCOLOGY; TUMORS;

DOSE ESCALATION; INTENSITY MODULATED RADIOTHERAPY (IMRT); POSITION VERIFICATION; PROSTATE CANCER; QUALITY OF LIFE (QOL);

RADIOTHERAPY;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DETERIORATION; EMOTIONALITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PAIN; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SEXUAL BEHAVIOR; URINARY DYSFUNCTION;

AGED; HEALTH STATUS; HUMANS; HYPERTHERMIA, INDUCED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 34548666745     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.013     Document Type: Article

References (27)

1. Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
2. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
3. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 294 (2005) 1233-1239
4. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116
5. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
6. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 (2001) 876-881
7. Van der Heide U.A., Dehnad H., Hofman P., et al. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 82 (2007) 38-45
8. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
9. Litwin M.S., Fitzpatrick J.M., Fossa S.D., et al. Defining an international research agenda for quality of life in men with prostate cancer. Prostate 41 (1999) 58-67
10. Van Gellekom M.P., Moerland M.A., van Vulpen M., et al. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Int J Radiat Oncol Biol Phys 63 (2005) 772-780
11. Van Vulpen M., De Leeuw J.R., Van Gellekom M.P., et al. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia 19 (2003) 402-413
12. Namiki S., Ishidoya S., Tochigi T., et al. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: Comparison with conformal and conformal radiotherapy. Jpn J Clin Oncol 36 (2006) 224-230
13. Little D.J., Kuban D.A., Levy L.B., et al. Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study. Urology 62 (2003) 707-713
14. Kupelian P.A., Reddy C.A., Klein E.A., et al. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life. Int J Radiat Oncol Biol Phys 51 (2001) 988-993
15. Trotti A. The evolution and application of toxicity criteria. Semin Radiat Oncol 12 (2002) 1-3
16. Hornbrook M.C., and Goodman M.J. Assessing relative health plan risk with the RAND-36 health survey. Inquiry 32 (1995) 56-74
17. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
18. Borghede G., and Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 5 (1996) 212-222
19. Henderson A., Laing R.W., and Langley S.E. Quality of life following treatment for early prostate cancer: Does low dose rate (LDR) brachytherapy offer a better outcome? A review. Eur Urol 45 (2004) 134-141
20. Osoba D., Rodrigues G., Myles J., et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16 (1998) 139-144
21. Breetvelt I.S., and van Dam F.S. Underreporting by cancer patients: The case of response shift. Soc Sci Med 32 (1991) 981-987
22. De Graeff A., de Leeuw J.R., Ros W.J., et al. Long-term quality of life of patients with head and neck cancer. Laryngoscope 110 (2000) 98-106
23. Wahlgren T., Brandberg Y., Haggarth L., et al. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: A prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25. Int J Radiat Oncol Biol Phys 60 (2004) 51-59
24. Korfage I.J., Essink-Bot M.L., Borsboom G.J., et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer 116 (2005) 291-296
25. Yoshimura K., Arai Y., Ichioka K., et al. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy. Prostate Cancer Prostatic Dis 7 (2004) 144-151
26. Van Andel G., Visser A.P., Zwinderman A.H., et al. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients. Prostate 58 (2004) 354-365
27. Bacon C.G., Giovannucci E., Testa M., et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 166 (2001) 1804-1810